Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases

Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases

Bibliographic Details
Main Authors:	Jianglei Li, Meihong Yu, Shifeng Fu, Deliang Liu, Yuyong Tan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Pharmacology
Subjects:	histone deacetylase 6 histone deacetylase inhibitor ACY-1215 cancer neurological diseases inflammatory diseases
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1117936/full

Similar Items

Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
by: Jianglei Li, et al.
Published: (2022-05-01)

Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice
by: Wen-bin Zhang, et al.
Published: (2019-06-01)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
by: Long Xu, et al.
Published: (2023-10-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
by: Jie Ran, et al.
Published: (2019-03-01)

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
by: Amandine Badie, et al.
Published: (2022-11-01)

Subcellular localization of class I histone deacetylases in the developing Xenopus tectum
by: Xia eGuo, et al.
Published: (2016-01-01)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
by: Fengyi Guo, et al.
Published: (2022-11-01)

Histone acetylation modifiers in the pathogenesis of Alzheimer’s disease
by: Xi eLu, et al.
Published: (2015-06-01)

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
by: Surabhi Shukla, et al.
Published: (2020-04-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
by: Luxi Wang, et al.
Published: (2023-04-01)

Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01)

Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
by: Ying Tang, et al.
Published: (2017-10-01)

Role of Histone Deacetylases in T-Cell Development and Function
by: Monika Pieniawska, et al.
Published: (2022-07-01)

Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
by: Subhasish Tapadar, et al.
Published: (2020-10-01)

In silico profiling of histone deacetylase inhibitory activity of compounds isolated from Cajanus cajan
by: Kayode Adewole, et al.
Published: (2022-01-01)

Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma
by: Maša Zrimšek, et al.
Published: (2022-08-01)

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
by: Richard S. Laschanzky, et al.
Published: (2019-09-01)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
by: Shan-qi Guo, et al.
Published: (2012-06-01)

Histone deacetylases facilitate the accurate repair of broken forks
by: Belén Gómez-González, et al.
Published: (2020-03-01)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016-05-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
by: Anton Frühauf, et al.
Published: (2021-08-01)

Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities
by: Baigalmaa Lkhagva, et al.
Published: (2018-04-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
by: Yan Li, et al.
Published: (2022-05-01)

Histone deacetylases exert class specific roles in conditioning the brain and heart against acute ischemic injury.
by: Sverre Erik Aune, et al.
Published: (2015-06-01)

Neddylation Regulates Class IIa and III Histone Deacetylases to Mediate Myoblast Differentiation
by: Hongyi Zhou, et al.
Published: (2021-09-01)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021-01-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Histone deacetylases and their roles in mineralized tissue regeneration
by: Nam Cong-Nhat Huynh, et al.
Published: (2017-12-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)